Consolidated Q2 Sep 2026: revenue INR795.21m, up 10%; post-tax profit INR95.09m, up 25.8% vs Q2 2025

EBITDA margin expansionRelated-party transactionsResults View source PDF Explain this filing

LAXMIDENTL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.3%Reaction day

₹182.13

prior close

₹181.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+2.2%+1.1% vs market

Medical Equipment & Supplies peers, median of 11sector+2.3%+0.9% vs sector

On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 0.9 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.4

10m

+0.8

15m

+0.5

30m

+2.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.3+2.2+1.1+2.3+0.9

Next day

+7.8+3.3+4.4+4.3+3.4

+8.7pendingpending+0.6+8.1

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 11Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

For the unaudited consolidated quarter ended 30 Sep 2026, revenue from operations was INR795.21m, up 10% vs INR722.65m a year earlier; profit after tax was INR95.09m, up 25.8% from INR75.57m. EBITDA margin widened to 19.2% from 15.3%. Standalone Q2 revenue rose 7.3%, but profit for the period fell 28.8%. Consolidated H1 operating cash flow was positive INR152.04m versus negative INR200.07m. Standalone H1 cash flow included a related-party loan.

Likely market impact

Positive but mixed for the stock: consolidated profit rose, standalone Q2 profit fell 28.8%, while cash flow and EBITDA margin improved.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹79.52 Cr	₹72.27 Cr	+10.0%
Operating profit	₹9.57 Cr	₹7.04 Cr	+36.0%
Profit after tax	₹10.04 Cr	₹8.53 Cr	+17.6%
EBITDA margin	19.2%	15.3%	+3.9 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.